Global Alzheimer's Disease Clinical Trials Review, H2, 2018 Featuring Pfizer, J&J, Eisai Co, F. Hoffmann-La Roche, Eli Lilly and Co, Novartis, AstraZeneca, Allergan,...
DUBLIN--(BUSINESS WIRE)--Feb 25, 2019--The "Alzheimer's Disease Global Clinical Trials Review, H2, 2018" clinical trials has been added to ResearchAndMarkets.com's offering.
